Bayer reports record Asia-Pac sales for 6th straight year on rising, ageing population
Singapore
GERMAN chemicals giant Bayer is on a high in the Asia-Pacific, reporting record sales for the sixth year running.
Pharmaceuticals sales are up 8.6 per cent at 4.8 billion euros (S$7.25 billion) for 2016. This is more than a quarter of its total sales worldwide, said Claus Zieler, senior vice-president and head of commercial operations at its Asia-Pacific pharmaceutical division.
He was speaking at a press conference held by Bayer Pharmaceuticals Apac on Tuesday.
The top five markets that delivered strong growth rates were India, Vietnam, South Korea, Pakistan and Taiwan, ranging from…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Digital Core Reit Q1 distributable income slips 2.4% to US$10.6 million
Hilton lifts 2024 profit forecast on international travel demand
Asia stocks rise on Wednesday amid Wall Street rally; STI up 0.6%
Orsted says Taiwan wind project to power TSMC on track for 2025 finish
China knockoff raid jolts a global throng of fake-fashion influencers
Tesla profits tumble but shares rise on new vehicle plan